IRIS
CAPRANZANO, PIERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.254
EU - Europa 2.435
AS - Asia 1.614
AF - Africa 338
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.661
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.028
IE - Irlanda 862
CN - Cina 791
SG - Singapore 639
UA - Ucraina 585
IT - Italia 409
CI - Costa d'Avorio 291
CA - Canada 225
RU - Federazione Russa 191
VN - Vietnam 133
SE - Svezia 119
FR - Francia 61
DE - Germania 55
SN - Senegal 41
GB - Regno Unito 39
IN - India 20
BE - Belgio 19
CH - Svizzera 18
NL - Olanda 18
UZ - Uzbekistan 17
AT - Austria 16
BR - Brasile 15
FI - Finlandia 14
GR - Grecia 12
PL - Polonia 7
EU - Europa 5
HK - Hong Kong 5
NG - Nigeria 4
BG - Bulgaria 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
LB - Libano 2
BZ - Belize 1
ES - Italia 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
KE - Kenya 1
KR - Corea 1
MT - Malta 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
TH - Thailandia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 10.661
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.119
Dublin 862
Jacksonville 807
Chandler 684
Houston 496
Singapore 448
Boardman 402
Abidjan 291
Nanjing 246
Chicago 223
Andover 215
Lawrence 214
Cambridge 213
Ashburn 173
Toronto 169
Des Moines 143
Catania 125
Dong Ket 125
Civitanova Marche 105
Nanchang 83
Wilmington 83
San Mateo 76
Hebei 64
Shenyang 53
Jiaxing 47
Ottawa 47
Saint Petersburg 45
Beijing 41
Dakar 41
Tianjin 39
Changsha 38
Los Angeles 32
Bremen 31
Washington 28
Moscow 23
Norwalk 20
Seattle 20
Brussels 19
Pune 18
Kunming 17
Ningbo 17
Falls Church 16
Hangzhou 15
Helsinki 14
Jinan 12
Den Haag 11
Guangzhou 11
Milan 11
Hanoi 8
Liberty Lake 8
Zhengzhou 8
Ann Arbor 7
Edinburgh 7
Palermo 7
Munich 6
Amsterdam 5
Canicattini Bagni 5
Manduria 5
Padova 5
Shanghai 5
Taizhou 5
Abuja 4
Assago 4
Casarano 4
Hong Kong 4
Ludwigshafen 4
Mascalucia 4
Acireale 3
Belo Horizonte 3
Catanzaro 3
Changchun 3
Frankfurt Am Main 3
Licata 3
Nanaimo 3
Phoenix 3
Pozzo Di Gotto 3
Prineville 3
Stockholm 3
Bussero 2
Cagliari 2
Civitavecchia 2
Fort Worth 2
Fremont 2
Fuzhou 2
Gela 2
Groningen 2
Kiev 2
Kilburn 2
Lanzhou 2
Maletto 2
Messina 2
Modena 2
Pavia 2
Potenza 2
Providence 2
Rio de Janeiro 2
San Jose 2
Shenzhen 2
Tappahannock 2
Taranto 2
Totale 8.214
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 505
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 117
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 107
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry 103
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 87
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 77
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 73
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 72
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 72
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 72
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 71
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 69
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 69
Clinical implication of different plaque distribution patterns in distal left main coronary artery 69
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 68
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 67
Current status of transcatheter valve therapy in Europe: results from an EAPCI survey 67
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 67
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 67
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 67
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 66
Appraisal of key trials in aortic and mitral fields 66
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 65
Early cardiovascular remodelling in Fabry disease 65
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 64
Retrograde Approach for Chronic Total Occlusion Percutaneous Coronary Intervention: The Paradox of Choice 64
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 64
Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry 64
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 64
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 63
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 63
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 63
Transfemoral transcatheter aortic-valve replacement should be preferred over surgery in most intermediate-risk patients. 63
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 62
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 62
Update on clinical evidence (Part II): a summary of the main post market studies 62
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 61
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 61
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 61
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 61
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 61
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 61
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 61
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 60
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 60
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 60
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 60
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary PCI 60
Transcatheter Aortic-Valve Replacement 59
Risk stratification after ST-elevation myocardial infarction 59
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 58
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 58
Authors' Reply 57
Early and Midterm Outcomes of Bioresorbable Scaffolds for Ostial Coronary Lesions: Insights from the GHOST-EU Registry 57
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease 57
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 56
Percutaneous Coronary Intervention With Everolimus-Eluting Bioresorbable Vascular Scaffolds In Routine Clinical Practice: Early and Mid-Term Outcomes From The European Multicenter GHOST-EU Registry 56
Strategies and Outcomes of Repeat Mitral Valve Interventions After Failed MitraClip Therapy 56
Capitolo 2 - Diagnostica cardiovascolare 56
L'angioplastica complessa al posto del by-pass: ruolo degli score di rischio 56
PHARMACODYNAMIC EFFECTS OF DIFFERENT ASPIRIN DOSING REGIMENS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CORONARY ARTERY DISEASE 56
Percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation in patients with surgical mitral valve repair failure. 55
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 55
Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry) 55
Serum cotinine levels are associated with increased clopidogrel-induced antiplatelet effects 54
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 54
CABG Versus PCI In Diabetic Patients With Multivessel Disease After Risk Stratification By The SYNTAX Score: A Pooled Analysis Of The SYNTAX And FREEDOM Trials 54
Real world safety and efficacy of the janus tacrolimus-eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting Stent (TEST) registry 53
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 53
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 53
Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation 53
Self-apposing STENTYS stent in acute myocardial infarction 53
Risk stratification for secondary prevention with ticagrelor and aspirin: a closer look to patient subsets from the PEGASUS-TIMI 54 trial 52
One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy? 52
Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry 52
Prasugrel: a novel platelet ADP P2Y(12) receptor antagonist. A review on its mechanism of action and clinical development 52
Impact of Chronic Kidney Disease on Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Insights From the GRASP Registry 52
Increasing CHADS2 scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleeding 52
Simultaneous plaque rupture and erosion in the same atheroma: insights from two and three-dimensional optical coherence tomography 51
Antiplatelet drug response variability and the role of platelet function testing: A practical guide for interventional cardiologists 51
Is isolated disease of the ostium left anterior descending or circumflex artery a distal left main pathology? 51
Clinical development of selective anticoagulants: a state of the art 50
Bioresorbable everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multi-center GHOST-EU registry 50
Drug-Eluting Stent for Left Main Coronary Artery Disease: The DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment 50
Parenteral Anticoagulant Agents in PCI 50
Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients. 50
Long-term outcomes after drug-eluting stent for the treatment of ostial left anterior descending coronary artery lesions 49
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: Results of the OPTIMUS-2 study 49
Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients 49
SES vs PES in patients with long lesions undergoing PCI: results from a 24 months follow up 49
How true delivery profile diminution reduces vascular access challenges and complications 48
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy 48
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 48
Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE registry) 48
Impact of Residual Platelet Reactivity on reperfusion in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention 48
Procedural management of patients with advanced heart failure undergoing MitraClip implantation (from the GRASP registry) 47
Infarto STEMI sottoposto a riperfusione con angioplastica primaria 47
Revascularization vs. Optimal Medical Therapy in Women with NSTE-ACS 47
Impact of Adjunctive Cilostazol Therapy Versus High Maintenance Dose of Clopidogrel in Suboptimal Responders With Diabetes Mellitus 47
Motivations for and barriers to choosing an interventional cardiology career path: Results from the EAPCI Women Committee worldwide survey 46
Totale 6.431
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020497 0 0 0 0 0 39 176 0 75 47 106 54
2020/20211.186 6 74 167 5 306 27 167 4 88 2 182 158
2021/20221.485 170 232 2 24 257 15 224 55 116 1 20 369
2022/20232.439 220 51 19 192 333 438 7 381 680 10 75 33
2023/20241.210 63 216 60 87 51 268 31 51 3 29 200 151
2024/20252.499 32 587 282 173 1.044 381 0 0 0 0 0 0
Totale 11.053